Literature DB >> 31043475

Influence of occlusion site and baseline ischemic core on outcome in patients with ischemic stroke.

Huiqiao Tian1, Mark W Parsons2, Christopher R Levi2, Longting Lin2, Richard I Aviv2, Neil J Spratt2, Kenneth S Butcher2, Min Lou2, Timothy J Kleinig2, Andrew Bivard2.   

Abstract

OBJECTIVE: We assessed patient clinical outcomes based on occlusion location, focusing on distal occlusions to understand if occlusion location was an independent predictor of outcome, and tested the relationship between occlusion location and baseline ischemic core, a known predictor of modified Rankin Scale (mRS) score at 90 days.
METHODS: We analyzed a prospectively collected cohort of thrombolysis-eligible ischemic stroke patients from the International Stroke Perfusion Imaging Registry who underwent multimodal CT pretreatment. For the primary analysis, logistic regression was used to predict the effect of occlusion location and ischemic core on the likelihood of excellent (mRS 0-1) and favorable (mRS 0-2) 90-day outcomes.
RESULTS: This study included 945 patients. The rates of excellent and favorable outcome in patients with distal occlusion (M2, M3 segment of middle cerebral artery, anterior cerebral artery, and posterior cerebral artery) were higher than M1 occlusions (mRS 0%-1%, 55% vs 37%; mRS 0%-2%, 73% vs 50%, p < 0.001). Vessel occlusion location was not a strong predictor of outcomes compared to baseline ischemic core (area under the curve, mRS 0-1, 0.64 vs 0.83; mRS 0-2, 0.70 vs 0.86, p < 0.001). There was no interaction between occlusion location and ischemic core (interaction coefficient 1.00, p = 0.798).
CONCLUSIONS: Ischemic stroke patients with a distal occlusion have higher rate of excellent and favorable outcome than patients with an M1 occlusion. The baseline ischemic core was shown to be a more powerful predictor of functional outcome than the occlusion location, but the relationship between ischemic core and outcome does not different by occlusion locations.
© 2019 American Academy of Neurology.

Entities:  

Year:  2019        PMID: 31043475     DOI: 10.1212/WNL.0000000000007553

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Medium Vessel Occlusion and Acute Ischemic Stroke: A Call for Treatment Paradigm Reappraisal.

Authors:  Eva A Mistry; Aaron S Dumont
Journal:  Stroke       Date:  2020-10-19       Impact factor: 7.914

Review 2.  A clinically relevant model of focal embolic cerebral ischemia by thrombus and thrombolysis in rhesus monkeys.

Authors:  Di Wu; Jian Chen; Longfei Wu; Hangil Lee; Jingfei Shi; Mo Zhang; Yanhui Ma; Xiaoduo He; Zixin Zhu; Feng Yan; Chuanjie Wu; Yunxia Duan; Yongjuan Fu; Sijie Li; Xinglong Zhi; Xuxiang Zhang; Shengli Li; Yuchuan Ding; Xunming Ji
Journal:  Nat Protoc       Date:  2022-06-27       Impact factor: 17.021

3.  Patient-Relevant Deficits Dictate Endovascular Thrombectomy Decision-Making in Patients with Low NIHSS Scores with Medium-Vessel Occlusion Stroke.

Authors:  R McDonough; P Cimflova; N Kashani; J M Ospel; M Kappelhof; N Singh; A Sehgal; N Sakai; J Fiehler; M Chen; M Goyal
Journal:  AJNR Am J Neuroradiol       Date:  2021-08-19       Impact factor: 4.966

4.  Eloquence-based reperfusion scoring and its ability to predict post-thrombectomy disability and functional status.

Authors:  Elliot Pressman; Victoria Sands; Gabriel Flores; Liwei Chen; Rahul Mhaskar; Waldo R Guerrero; Zeguang Ren; Maxim Mokin
Journal:  Interv Neuroradiol       Date:  2021-10-14       Impact factor: 1.764

5.  What Is the "Optimal" Target Mismatch Criteria for Acute Ischemic Stroke?

Authors:  Chushuang Chen; Mark W Parsons; Christopher R Levi; Neil J Spratt; Longting Lin; Timothy Kleinig; Kenneth Butcher; Xin Cheng; Qiang Dong; Billy O'Brien; Richard I Avivi; Martin Krause; P N Sylaja; Philip Choi; Sandeep Bhuta; Congguo Yin; Jianhong Yang; Peng Wang; Weiwen Qiu; Andrew Bivard
Journal:  Front Neurol       Date:  2021-01-13       Impact factor: 4.003

6.  Early recanalization in large-vessel occlusion stroke patients transferred for endovascular treatment.

Authors:  Nerea Arrarte Terreros; Agnetha A E Bruggeman; Isabella S J Swijnenburg; Laura C C van Meenen; Adrien E Groot; Jonathan M Coutinho; Yvo B W E M Roos; Bart J Emmer; Ludo F M Beenen; Ed van Bavel; Henk A Marquering; Charles B L M Majoie
Journal:  J Neurointerv Surg       Date:  2021-05-13       Impact factor: 8.572

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.